For instance, cancer cells with upregulated PD-L1 expression can protect tumor cells from cytotoxic T lymphocyte (CTL)-mediated cytolysis and from the cytotoxic effects of type 1 and type II interferons through reverse PD-L1 signaling within cancer cells, without PD-1 signaling in T cells. Here, CD274 is linked to neoplasm.